143 related articles for article (PubMed ID: 8304928)
1. Multiple mechanisms: the example of vitamin A.
De Luca LM
Basic Life Sci; 1993; 61():17-25. PubMed ID: 8304928
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer.
Niles RM
Nutrition; 2000; 16(11-12):1084-9. PubMed ID: 11118831
[TBL] [Abstract][Full Text] [Related]
3. Dietary retinoids are essential for skin papilloma formation induced by either the two-stage or the complete tumorigenesis model in female SENCAR mice.
De Luca LM; Sly L; Jones CS; Chen LC
Cancer Lett; 1992 Oct; 66(3):233-9. PubMed ID: 1451104
[TBL] [Abstract][Full Text] [Related]
4. Retinoids in chemoprevention and differentiation therapy.
Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
6. High dietary retinoic acid prevents malignant conversion of skin papillomas induced by a two-stage carcinogenesis protocol in female SENCAR mice.
Chen LC; Sly L; De Luca LM
Carcinogenesis; 1994 Oct; 15(10):2383-6. PubMed ID: 7955082
[TBL] [Abstract][Full Text] [Related]
7. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.
Huang C; Ma WY; Dawson MI; Rincon M; Flavell RA; Dong Z
Proc Natl Acad Sci U S A; 1997 May; 94(11):5826-30. PubMed ID: 9159159
[TBL] [Abstract][Full Text] [Related]
8. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia.
De Luca LM
FASEB J; 1991 Nov; 5(14):2924-33. PubMed ID: 1661245
[TBL] [Abstract][Full Text] [Related]
9. Retinoids as cancer-preventive agents.
Sankaranarayanan R; Mathew B
IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the ability of retinoids to inhibit promoter-induced anchorage-independent growth of JB6 mouse epidermal cells with their activation of retinoic acid receptor gamma.
Rudd CJ; Mansbridge JN; Suing KD; Dawson MI
Cancer Lett; 1993 Sep; 73(1):41-9. PubMed ID: 8402597
[TBL] [Abstract][Full Text] [Related]
11. The promise of retinoids to fight against cancer.
Altucci L; Gronemeyer H
Nat Rev Cancer; 2001 Dec; 1(3):181-93. PubMed ID: 11902573
[TBL] [Abstract][Full Text] [Related]
12. Retinoids in cancer chemoprevention.
Lotan R
FASEB J; 1996 Jul; 10(9):1031-9. PubMed ID: 8801164
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-promoted tumor formation in CD-1 and Sencar mice.
Dawson MI; Chao WR
Cancer Lett; 1988 May; 40(1):7-12. PubMed ID: 3130981
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of initiator-promoter-induced skin tumorigenesis in female SENCAR mice fed a vitamin A-deficient diet and reappearance of tumors in mice fed a diet adequate in retinoid or beta-carotene.
De Luca LM; Shores RL; Spangler EF; Wenk ML
Cancer Res; 1989 Oct; 49(19):5400-6. PubMed ID: 2504490
[TBL] [Abstract][Full Text] [Related]
15. Retinoids and their receptors in cancer development and chemoprevention.
Sun SY; Lotan R
Crit Rev Oncol Hematol; 2002 Jan; 41(1):41-55. PubMed ID: 11796231
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
17. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
Niles RM
Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
[TBL] [Abstract][Full Text] [Related]
18. Retinoids in chemoprevention of cancer.
Verma AK
J Biol Regul Homeost Agents; 2003; 17(1):92-7. PubMed ID: 12757023
[TBL] [Abstract][Full Text] [Related]
19. Retinoids--"differentiation agents" for cancer treatment and prevention.
Hofmann SL
Am J Med Sci; 1992 Sep; 304(3):202-13. PubMed ID: 1335685
[TBL] [Abstract][Full Text] [Related]
20. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.
Lahiri-Chatterjee M; Katiyar SK; Mohan RR; Agarwal R
Cancer Res; 1999 Feb; 59(3):622-32. PubMed ID: 9973210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
